MBX Biosciences: Director Departs, New Officers Elected
Ticker: MBX · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1776111
Sentiment: neutral
Topics: management-change, corporate-governance, officer-appointment
TL;DR
MBX Bio director out, new execs in, shareholder votes coming up.
AI Summary
MBX Biosciences, Inc. announced on June 5, 2025, the departure of Director David E. Johnson. The company also reported on the election of new directors and the appointment of certain officers, along with details on compensatory arrangements for these officers. Additionally, the filing covers the submission of matters to a vote of security holders.
Why It Matters
Changes in board composition and officer appointments can signal shifts in company strategy or leadership, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in key personnel and upcoming shareholder votes introduce a degree of uncertainty regarding future company direction and governance.
Key Numbers
- 001-42272 — SEC File Number (Identifies the company's filing history with the SEC.)
- 1231 — Fiscal Year End (Indicates the end of the company's annual accounting period.)
Key Players & Entities
- MBX Biosciences, Inc. (company) — Registrant
- David E. Johnson (person) — Departing Director
- June 05, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Carmel, Indiana (location) — Principal Executive Offices
FAQ
Who has departed from the board of directors at MBX Biosciences, Inc.?
David E. Johnson has departed from the board of directors.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 05, 2025.
In which state was MBX Biosciences, Inc. incorporated?
MBX Biosciences, Inc. was incorporated in Delaware.
What is the address of MBX Biosciences, Inc.'s principal executive offices?
The principal executive offices are located at 11711 N. Meridian Street, Suite 300, Carmel, Indiana 46032.
Besides director departure, what other key items are reported in this 8-K?
The filing also reports on the election of directors, appointment of certain officers, compensatory arrangements for officers, and the submission of matters to a vote of security holders.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 by David E. Johnson regarding MBX Biosciences, Inc. (MBX).